Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Obese/Overweight Patients with Bipolar Disorder
NCT03158805Phase 2Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Apr 2017
- Primary completion
- Oct 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in obesity, Overweight, sponsored by Lindner Center of HOPE. Started Apr 2017; status: completed.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT03158805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03158805.